» Articles » PMID: 34511042

Long Non-coding RNA SOX21-AS1 Modulates Lung Cancer Progress Upon MicroRNA MiR-24-3p/PIM2 Axis

Overview
Journal Bioengineered
Date 2021 Sep 13
PMID 34511042
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer is a lethal cancer that threatens human health. Several studies have demonstrated the role of long non-coding RNAs (lncRNAs) in lung cancer. is a newly discovered oncogenic lncRNA, but its molecular mechanism in lung cancer is not known. Here, the levels of , and PIM2 were examined in lung cancer and normal tissues. The relationships between and or PIM2 were predicted using bioinformatics tools and confirmed using a luciferase reporter assays. Colony formation, MTT, flow cytometry, and transwell assays were conducted to analyze cell proliferation, apoptosis, migration, and invasion abilities, respectively. Western blotting was used to measure PIM2 expression levels in cancer tissues and cells. expression levels were high in lung cancer tissues and cells. In contrast, the amount of bound to was relatively low in cancerous tissues and cells. The knockdown of decreased cell proliferation, activated apoptosis, and promoted cell migration and invasion. These effects were abolished by inhibition. The oncogenic function of mediated through targeting was also demonstrated in animal models. PIM2 was targeted by and showed increased levels in tumor tissues and cells. Furthermore, overexpression inhibited the proliferation and promoted the apoptosis of lung cancer cells. In lung cancer cells, negatively modulated the /PIM2 axis to facilitate their proliferation, migration, and invasion. These findings offer a novel idea for future research on treating lung cancer at the molecular level.

Citing Articles

Exosomal lncRNA HCP5 derived from human bone marrow mesenchymal stem cells improves chronic periodontitis by miR-24-3p/// pathway.

Liu Y, Zhu J, Wang W, Zeng L, Yang Y, Wang Z Heliyon. 2024; 10(14):e34203.

PMID: 39104492 PMC: 11298838. DOI: 10.1016/j.heliyon.2024.e34203.


High CASC expression predicts poor prognosis of lung cancer: A systematic review with meta-analysis.

Han H, Huang H, Chen A, Tang Y, Huang X, Chen C PLoS One. 2024; 19(4):e0292726.

PMID: 38573879 PMC: 10994294. DOI: 10.1371/journal.pone.0292726.


Long noncoding RNA lnc-SNAPC5-3:4 inhibits malignancy by directly upregulating miR-224-3p in non-small cell lung cancer.

Hu C, Wu S, Sun W, Li J, Hui K, Jiang X Heliyon. 2024; 10(2):e24668.

PMID: 38312596 PMC: 10835238. DOI: 10.1016/j.heliyon.2024.e24668.


LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration.

Tian Q, Liu X, Li A, Wu H, Xie Y, Zhang H PeerJ. 2023; 11:e16447.

PMID: 38084139 PMC: 10710776. DOI: 10.7717/peerj.16447.


A prognostic signature for lung adenocarcinoma by five genes associated with chemotherapy in lung adenocarcinoma.

Li X, Xu C, Min Y, Zhai Z, Zhu Y Clin Respir J. 2023; 17(12):1349-1360.

PMID: 38071755 PMC: 10730453. DOI: 10.1111/crj.13723.


References
1.
Lei K, Kao C, Tsang N . High throughput and automatic colony formation assay based on impedance measurement technique. Anal Bioanal Chem. 2017; 409(12):3271-3277. DOI: 10.1007/s00216-017-0270-5. View

2.
Deng S, Chen H, Ye Z, Deng S, Zhu S, Zeng Z . Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Oncogene. 2018; 37(44):5811-5828. DOI: 10.1038/s41388-018-0382-1. View

3.
Wei A, Li L . Long non-coding RNA SOX21-AS1 sponges miR-145 to promote the tumorigenesis of colorectal cancer by targeting MYO6. Biomed Pharmacother. 2017; 96:953-959. DOI: 10.1016/j.biopha.2017.11.145. View

4.
He X, Dai J, Fan Y, Zhang C, Zhao X . Regulation function of MMP-1 downregulated by siRNA on migration of heat-denatured dermal fibroblasts. Bioengineered. 2017; 8(6):686-692. PMC: 5736340. DOI: 10.1080/21655979.2016.1267885. View

5.
Marshall J . Transwell(®) invasion assays. Methods Mol Biol. 2011; 769:97-110. DOI: 10.1007/978-1-61779-207-6_8. View